These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19821486)

  • 1. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Itsui Y; Sakamoto N; Kakinuma S; Nakagawa M; Sekine-Osajima Y; Tasaka-Fujita M; Nishimura-Sakurai Y; Suda G; Karakama Y; Mishima K; Yamamoto M; Watanabe T; Ueyama M; Funaoka Y; Azuma S; Watanabe M
    Hepatology; 2009 Dec; 50(6):1727-37. PubMed ID: 19821486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylate-Binding Protein 1, an Interferon-Induced GTPase, Exerts an Antiviral Activity against Classical Swine Fever Virus Depending on Its GTPase Activity.
    Li LF; Yu J; Li Y; Wang J; Li S; Zhang L; Xia SL; Yang Q; Wang X; Yu S; Luo Y; Sun Y; Zhu Y; Munir M; Qiu HJ
    J Virol; 2016 May; 90(9):4412-4426. PubMed ID: 26889038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
    Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.
    Marukian S; Andrus L; Sheahan TP; Jones CT; Charles ED; Ploss A; Rice CM; Dustin LB
    Hepatology; 2011 Dec; 54(6):1913-23. PubMed ID: 21800339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
    Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
    Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.
    Frese M; Pietschmann T; Moradpour D; Haller O; Bartenschlager R
    J Gen Virol; 2001 Apr; 82(Pt 4):723-733. PubMed ID: 11257176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
    Gao Y; Yu X; Xue B; Zhou F; Wang X; Yang D; Liu N; Xu L; Fang X; Zhu H
    PLoS One; 2014; 9(2):e90333. PubMed ID: 24587329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HCV structural proteins impairs IFN-mediated antiviral response.
    Keskinen P; Melén K; Julkunen I
    Virology; 2002 Aug; 299(2):164-71. PubMed ID: 12202219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.
    Carter CC; Gorbacheva VY; Vestal DJ
    Arch Virol; 2005 Jun; 150(6):1213-20. PubMed ID: 15717119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model.
    Sumpter R; Wang C; Foy E; Loo YM; Gale M
    J Virol; 2004 Nov; 78(21):11591-604. PubMed ID: 15479800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
    Jiang D; Guo H; Xu C; Chang J; Gu B; Wang L; Block TM; Guo JT
    J Virol; 2008 Feb; 82(4):1665-78. PubMed ID: 18077728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.
    Ishida Y; Kakuni M; Bang BR; Sugahara G; Lau DT; Tateno-Mukaidani C; Li M; Gale M; Saito T
    J Interferon Cytokine Res; 2019 Mar; 39(3):133-146. PubMed ID: 30844328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
    Yu X; Gao Y; Xue B; Wang X; Yang D; Qin Y; Yu R; Liu N; Xu L; Fang X; Zhu H
    Antiviral Res; 2014 Jun; 106():116-24. PubMed ID: 24713119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.